134 related articles for article (PubMed ID: 23524311)
1. Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines.
Lwaleed BA; Lam L; Lasebai M; Cooper AJ
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):339-43. PubMed ID: 23524311
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
3. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
4. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
5. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
6. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
7. Prothrombotic effect of prostasomes of metastatic cell and seminal origin.
Babiker AA; Hamad OA; Sanchez J; Ronquist G; Nilsson B; Ekdahl KN
Prostate; 2007 Mar; 67(4):378-88. PubMed ID: 17219380
[TBL] [Abstract][Full Text] [Related]
8. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
[TBL] [Abstract][Full Text] [Related]
9. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
[TBL] [Abstract][Full Text] [Related]
10. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
11. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
12. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
13. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
[TBL] [Abstract][Full Text] [Related]
14. Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression.
Lindholm PF; Lu Y; Adley BP; Vladislav T; Jovanovic B; Sivapurapu N; Yang XJ; Kajdacsy-Balla A
Prostate; 2010 Nov; 70(15):1672-82. PubMed ID: 20607747
[TBL] [Abstract][Full Text] [Related]
15. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
[TBL] [Abstract][Full Text] [Related]
17. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor/TFPI and blood cells.
Osterud B
Thromb Res; 2012 Mar; 129(3):274-8. PubMed ID: 22197177
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin reduces the production of prothrombotic prostasomes in human prostate cancer cells.
Aberg M; Johnell M; Wickström M; Widunder A; Siegbahn A
Thromb Haemost; 2008 Oct; 100(4):655-62. PubMed ID: 18841289
[TBL] [Abstract][Full Text] [Related]
20. Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation.
Świtońska M; Słomka A; Sinkiewicz W; Żekanowska E
Eur J Neurol; 2015 Feb; 22(2):395-401, e28-9. PubMed ID: 25370815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
